Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recombinant technology in transfusion medicine.

¹University of the West of England, Frenchay, Bristol, UK. neil.avent@uwe.ac.uk

Current Pharmaceutical Biotechnology

|July 27, 2001

Summary

Recombinant DNA technology is revolutionizing transfusion medicine, impacting diagnostics and product development. Future applications in molecular diagnostics and gene therapy promise significant advancements in patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Maternal plasma biomarkers for down syndrome: present and future.

Drugs of today (Barcelona, Spain : 1998)·2013

Same author

Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells.

Diabetologia·2010

Same author

Toxicity testing: the search for an in vitro alternative to animal testing.

British journal of biomedical science·2009

Same author

The Escherichia coli AmtB protein as a model system for understanding ammonium transport by Amt and Rh proteins.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2006

Same author

Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.

Transfusion·2002

Same author

Molecular biology of the Rh blood group system.

Journal of pediatric hematology/oncology·2001

Area of Science:

Transfusion Medicine
Molecular Biology
Biotechnology

Background:

Recombinant technology's large-scale impact in transfusion medicine is emerging.
Current practices in blood product preparation and antibody detection largely exclude DNA-based methods.
Recombinant DNA technologies are increasingly integrated into bloodborne virus detection, reagent production, and HLA polymorphism diagnosis.

Purpose of the Study:

To review the current applications of recombinant technology in transfusion medicine.
To identify areas of significant future development, particularly in molecular diagnostics.
To explore the potential impact of molecular medicine on transfusion practices.

Main Methods:

Literature review of recombinant DNA technologies in transfusion medicine.
Analysis of current and emerging applications.
Discussion of potential future impacts of molecular medicine.

Main Results:

Recombinant DNA technology is currently used in detecting bloodborne viruses, producing blood grouping reagents, and diagnosing HLA polymorphism.
The licensing of thrombopoietin may reduce demand for platelet transfusions.
Gene therapy and recombinant blood products could alter the need for plasma-derived clotting factors.

Conclusions:

Recombinant technology is poised to significantly reshape transfusion medicine over the next decade, especially in molecular diagnostics.
Emerging technologies like DNA arraying and nucleic acid therapeutics hold promise for diagnostics and leukemia treatment.
The integration of molecular medicine is transforming transfusion practices and patient outcomes.

Related Experiment Videos